{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:24:21Z","timestamp":1780550661952,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41434-020-00191-0","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T10:09:21Z","timestamp":1599818961000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of miR-144-3p alleviates polycystic ovaries syndrome through targeting expression of HSP-70"],"prefix":"10.1038","volume":"29","author":[{"given":"Bing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-2657","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-4527","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"191_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/0378-6323.110759","volume":"79","author":"N Madnani","year":"2013","unstructured":"Madnani N, Khan K, Chauhan P, Parmar G. Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol. 2013;79:310\u201321.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"191_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocrine Soc. 2019;3:1545\u201373.","journal-title":"J Endocrine Soc"},{"key":"191_CR3","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol. Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol. Metab"},{"key":"191_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","volume":"99","author":"S Trikudanathan","year":"2015","unstructured":"Trikudanathan S. Polycystic ovarian syndrome. Med Clinics North Am. 2015;99:221\u201335.","journal-title":"Med Clinics North Am"},{"key":"191_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2007-1650","volume":"93","author":"M Das","year":"2008","unstructured":"Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:881\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a137638","volume":"7","author":"GF Erickson","year":"1992","unstructured":"Erickson GF, Magoffin DA, Garzo VG, Cheung AP, Chang RJ. Granulosa cells of polycystic ovaries: are they normal or abnormal? Hum Reprod. 1992;7:293\u20139.","journal-title":"Hum Reprod"},{"key":"191_CR7","first-page":"1","volume":"342","author":"SY Ying","year":"2006","unstructured":"Ying SY, Chang DC, Miller JD, Lin SL. The microRNA: overview of the RNA gene that modulates gene functions. Methods Mol Biol. 2006;342:1\u201318.","journal-title":"Methods Mol Biol"},{"key":"191_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0300985813502820","volume":"51","author":"M Bhaskaran","year":"2014","unstructured":"Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Veterinary Pathol. 2014;51:759\u201374.","journal-title":"Veterinary Pathol"},{"key":"191_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jgg.2011.11.007","volume":"39","author":"MA Dehwah","year":"2012","unstructured":"Dehwah MA, Xu A, Huang Q. MicroRNAs and type 2 diabetes\/obesity. J Gen Gnom. 2012;39:11\u20138.","journal-title":"J Gen Gnom"},{"key":"191_CR10","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1210\/jc.2013-1715","volume":"98","author":"Q Sang","year":"2013","unstructured":"Sang Q, Yao Z, Wang H, Feng R, Wang H, Zhao X, et al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab. 2013;98:3068\u201379.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/genes5030684","volume":"5","author":"AE Sorensen","year":"2014","unstructured":"Sorensen AE, Wissing ML, Salo S, Englund AL, Dalgaard LT. MicroRNAs related to polycystic ovary syndrome (PCOS). Genes. 2014;5:684\u2013708.","journal-title":"Genes"},{"key":"191_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12958-019-0505-8","volume":"17","author":"T He","year":"2019","unstructured":"He T, Sun Y, Zhang Y, Zhao S, Zheng Y, Hao G, et al. MicroRNA-200b and microRNA-200c are up-regulated in PCOS granulosa cell and inhibit KGN cell proliferation via targeting PTEN. Rep Biol Endocrinol. 2019;17:68.","journal-title":"Rep Biol Endocrinol"},{"key":"191_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1159\/000491894","volume":"48","author":"X Fu","year":"2018","unstructured":"Fu X, He Y, Wang X, Peng D, Chen X, Li X, et al. MicroRNA-16 promotes ovarian granulosa cell proliferation and suppresses apoptosis through targeting PDCD4 in polycystic ovarian syndrome. Cell Physiol Biochem. 2018;48:670\u201382.","journal-title":"Cell Physiol Biochem"},{"key":"191_CR14","first-page":"7217","volume":"23","author":"XM Han","year":"2019","unstructured":"Han XM, Tian PY, Zhang JL. MicroRNA-486-5p inhibits ovarian granulosa cell proliferation and participates in the development of PCOS via targeting MST4. Eur Rev Med Pharmacol Sci. 2019;23:7217\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"191_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3233\/CBM-170351","volume":"20","author":"S Liu","year":"2017","unstructured":"Liu S, Suo J, Wang C, Sun X, Wang D, He L, et al. Prognostic significance of low miR-144 expression in gastric cancer. Cancer Biomarkers: Sect A Dis Mark. 2017;20:547\u201352.","journal-title":"Cancer Biomarkers: Sect A Dis Mark"},{"key":"191_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/dna.2017.3656","volume":"36","author":"J Li","year":"2017","unstructured":"Li J, Sun P, Yue Z, Zhang D, You K, Wang J. miR-144-3p induces cell cycle arrest and apoptosis in pancreatic cancer cells by targeting proline-rich protein 11 expression via the mitogen-activated protein kinase signaling pathway. DNA Cell Biol. 2017;36:619\u201326.","journal-title":"DNA Cell Biol"},{"key":"191_CR17","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1002\/cam4.1714","volume":"7","author":"C Liu","year":"2018","unstructured":"Liu C, Yang Z, Deng Z, Zhou Y, Gong Q, Zhao R, et al. Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2. Cancer Med. 2018;7:5554\u201366.","journal-title":"Cancer Med"},{"key":"191_CR18","first-page":"4079","volume":"21","author":"ZX Cheng","year":"2017","unstructured":"Cheng ZX, Song YX, Wang ZY, Wang Y, Dong Y. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma. Eur Rev Med Pharmacol Sci. 2017;21:4079\u201386.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"191_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","volume":"706","author":"B Chen","year":"2019","unstructured":"Chen B, Xu P, Wang J, Zhang C. The role of MiRNA in polycystic ovary syndrome (PCOS). Gene. 2019;706:91\u201396.","journal-title":"Gene"},{"key":"191_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.acc.2015.06.001","volume":"71","author":"IR Ilie","year":"2015","unstructured":"Ilie IR, Georgescu CE. Polycystic ovary syndrome-epigenetic mechanisms and aberrant MicroRNA. Adv Clin Chem. 2015;71:25\u201345.","journal-title":"Adv Clin Chem"},{"key":"191_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0162-2","volume":"8","author":"Y Li","year":"2015","unstructured":"Li Y, Fang Y, Liu Y, Yang X. MicroRNAs in ovarian function and disorders. J Ovarian Res. 2015;8:51.","journal-title":"J Ovarian Res"},{"key":"191_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1055\/s-0028-1096127","volume":"26","author":"T Toloubeydokhti","year":"2008","unstructured":"Toloubeydokhti T, Bukulmez O, Chegini N. Potential regulatory functions of microRNAs in the ovary. Sem Reprod Med. 2008;26:469\u201378.","journal-title":"Sem Reprod Med"},{"key":"191_CR23","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1210\/jc.2007-0729","volume":"92","author":"SA Stubbs","year":"2007","unstructured":"Stubbs SA, Stark J, Dilworth SM, Franks S, Hardy K. Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab. 2007;92:4418\u201326.","journal-title":"J Clin Endocrinol Metab"},{"key":"191_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14:105\u201311.","journal-title":"Cell Stress Chaperones"},{"key":"191_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2017.00254","volume":"11","author":"RE Lackie","year":"2017","unstructured":"Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, et al. The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases. Front Neurosci. 2017;11:254.","journal-title":"Front Neurosci"},{"key":"191_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-319-51409-3_6","volume":"222","author":"SS Witkin","year":"2017","unstructured":"Witkin SS, Kanninen TT, Sisti G. The role of Hsp70 in the regulation of autophagy in gametogenesis, pregnancy, and parturition. Adv Anat Embryol Cell Biol. 2017;222:117\u201327.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"191_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000189809","volume":"18","author":"X Ruan","year":"2009","unstructured":"Ruan X, Dai Y. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome. Med Princ Pract. 2009;18:118\u201322.","journal-title":"Med Princ Pract"},{"key":"191_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12192-008-0067-8","volume":"14","author":"A Molvarec","year":"2009","unstructured":"Molvarec A, Rigo J Jr, Lazar L, Balogh K, Mako V, Cervenak L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones. 2009;14:151\u20139.","journal-title":"Cell Stress Chaperones"},{"key":"191_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jri.2013.08.003","volume":"100","author":"JC Peracoli","year":"2013","unstructured":"Peracoli JC, Bannwart-Castro CF, Romao M, Weel IC, Ribeiro VR, Borges VT, et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia. J Reprod Immun. 2013;100:129\u201334.","journal-title":"J Reprod Immun"},{"key":"191_CR30","doi-asserted-by":"publisher","first-page":"e67727","DOI":"10.1371\/journal.pone.0067727","volume":"8","author":"H Gao","year":"2013","unstructured":"Gao H, Meng J, Xu M, Zhang S, Ghose B, Liu J, et al. Serum heat shock protein 70 concentration in relation to polycystic ovary syndrome in a non-obese chinese population. PloS ONE. 2013;8:e67727.","journal-title":"PloS ONE"},{"key":"191_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0548-7","volume":"12","author":"G Wu","year":"2019","unstructured":"Wu G, Hu X, Ding J, Yang J. Abnormal expression of HSP70 may contribute to PCOS pathology. J Ovarian Res. 2019;12:74.","journal-title":"J Ovarian Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00191-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00191-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00191-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:08:04Z","timestamp":1654067284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-020-00191-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1038\/s41434-020-00191-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"14 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}